Postcontrast Acute Kidney Injury After Transarterial Chemoembolization

Ali Kord; Simon J. Park; Amith Rao; Atul Eppurath; Andrew Lipnik; Charles E. Ray

doi:10.1055/s-0041-1724016

Seminars in Interventional Radiology, Inhaltsverzeichnis

Semin intervent Radiol 2021; 38(01): 139-143
DOI: 10.1055/s-0041-1724016

Morbidity & Mortality

Postcontrast Acute Kidney Injury After Transarterial Chemoembolization

Ali Kord

¹Division of Interventional Radiology, Department of Radiology, University of Illinois College of Medicine, Chicago, Illinois

,

Simon J. Park

¹Division of Interventional Radiology, Department of Radiology, University of Illinois College of Medicine, Chicago, Illinois

,

Amith Rao

¹Division of Interventional Radiology, Department of Radiology, University of Illinois College of Medicine, Chicago, Illinois

,

Atul Eppurath

¹Division of Interventional Radiology, Department of Radiology, University of Illinois College of Medicine, Chicago, Illinois

,

Andrew Lipnik

¹Division of Interventional Radiology, Department of Radiology, University of Illinois College of Medicine, Chicago, Illinois

,

Charles E. Ray

¹Division of Interventional Radiology, Department of Radiology, University of Illinois College of Medicine, Chicago, Illinois

References
1 American Board of Radiology. Noninterpretive Skills. 2020: 23-29 . Accessed September 15, 2020 at: https://www.theabr.org/wp-content/uploads/2020/02/NIS-Study-Guide-2020.pdf
2 Stacul F, van der Molen AJ, Reimer P. et al; Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 2011; 21 (12) 2527-2541
3 ACR Committee on Drugs and Contrast Media. ACR Manual on Contrast Media: ACR. 2020: 33-45 . Accessed September 15, 2020 at: https://www.acr.org/-/media/ACR/Files/Clinical-Resources/Contrast_Media.pdf
4 The Kidney Disease: Improving Global Outcomes. KDIGO Clinical Practice Guideline for acute kidney injury. Kidney Int 2012; 2: 1-113
5 van der Molen AJ, Reimer P, Dekkers IA. et al. Post-contrast acute kidney injury - Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors: recommendations for updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol 2018; 28 (07) 2845-2855
6 Davenport MS, Perazella MA, Yee J. et al. Use of intravenous iodinated contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National Kidney Foundation. Radiology 2020; 294 (03) 660-668
7 Sendeski MM. Pathophysiology of renal tissue damage by iodinated contrast media. Clin Exp Pharmacol Physiol 2011; 38 (05) 292-299
8 Andreucci M, Faga T, Pisani A, Sabbatini M, Michael A. Acute kidney injury by radiographic contrast media: pathogenesis and prevention. BioMed Res Int 2014; 2014: 362725
9 Detrenis S, Meschi M, Musini S, Savazzi G. Lights and shadows on the pathogenesis of contrast-induced nephropathy: state of the art. Nephrol Dial Transplant 2005; 20 (08) 1542-1550
10 Andreucci M, Solomon R, Tasanarong A. Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention. BioMed Res Int 2014; 2014: 741018
11 Kohan DE, Inscho EW, Wesson D, Pollock DM. Physiology of endothelin and the kidney. Compr Physiol 2011; 1 (02) 883-919
12 Margulies KB, Hildebrand FL, Heublein DM, Burnett Jr JC. Radiocontrast increases plasma and urinary endothelin. J Am Soc Nephrol 1991; 2 (05) 1041-1045
13 Ulas T, Buyukhatipoglu H, Dal MS. et al. Urotensin-II and endothelin-I levels after contrast media administration in patients undergoing percutaneous coronary interventions. J Res Med Sci 2013; 18 (03) 205-209
14 Heyman SN, Rosenberger C, Rosen S, Khamaisi M. Why is diabetes mellitus a risk factor for contrast-induced nephropathy?. BioMed Res Int 2013; 2013: 123589
15 Kalani M. The importance of endothelin-1 for microvascular dysfunction in diabetes. Vasc Health Risk Manag 2008; 4 (05) 1061-1068
16 Lee J. Nitric oxide in the kidney: its physiological role and pathophysiological implications. Electrolyte Blood Press 2008; 6 (01) 27-34
17 Ozkok S, Ozkok A. Contrast-induced acute kidney injury: a review of practical points. World J Nephrol 2017; 6 (03) 86-99
18 Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int 2005; 68 (01) 14-22
19 Pattharanitima P, Tasanarong A. Pharmacological strategies to prevent contrast-induced acute kidney injury. BioMed Res Int 2014; 2014: 236930
20 Solomon R. Contrast media: are there differences in nephrotoxicity among contrast media?. BioMed Res Int 2014; 2014: 934947
21 Bucher AM, De Cecco CN, Schoepf UJ. et al. Is contrast medium osmolality a causal factor for contrast-induced nephropathy?. BioMed Res Int 2014; 2014: 931413
22 Pflueger A, Larson TS, Nath KA, King BF, Gross JM, Knox FG. Role of adenosine in contrast media-induced acute renal failure in diabetes mellitus. Mayo Clin Proc 2000; 75 (12) 1275-1283
23 Mueller C, Buerkle G, Buettner HJ. et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002; 162 (03) 329-336
24 Weisbord SD, Palevsky PM. Prevention of contrast-induced nephropathy with volume expansion. Clin J Am Soc Nephrol 2008; 3 (01) 273-280
25 Merten GJ, Burgess WP, Gray LV. et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004; 291 (19) 2328-2334
26 Zoungas S, Ninomiya T, Huxley R. et al. Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy. Ann Intern Med 2009; 151 (09) 631-638
27 Hiremath S, Akbari A, Shabana W, Fergusson DA, Knoll GA. Prevention of contrast-induced acute kidney injury: is simple oral hydration similar to intravenous? A systematic review of the evidence. PLoS One 2013; 8 (03) e60009
28 Søreide E, Ljungqvist O. Modern preoperative fasting guidelines: a summary of the present recommendations and remaining questions. Best Pract Res Clin Anaesthesiol 2006; 20 (03) 483-491
29 Subramaniam RM, Suarez-Cuervo C, Wilson RF. et al. Effectiveness of prevention strategies for contrast-induced nephropathy: a systematic review and meta-analysis. Ann Intern Med 2016; 164 (06) 406-416
30 Pappy R, Stavrakis S, Hennebry TA, Abu-Fadel MS. Effect of statin therapy on contrast-induced nephropathy after coronary angiography: a meta-analysis. Int J Cardiol 2011; 151 (03) 348-353
31 Li Y, Liu Y, Fu L, Mei C, Dai B. Efficacy of short-term high-dose statin in preventing contrast-induced nephropathy: a meta-analysis of seven randomized controlled trials. PLoS One 2012; 7 (04) e34450